Significant Accounting Policies (Tables)

6 Months Ended

Oct. 31, 2024

Accounting Policies [Abstract]

Schedule of the calculation of earnings (loss) per share, basic and diluted

The following table reflects these calculations. As of October 31, 2023, all of the Company's potential common stock was considered anti-dilutive due to the Company's net losses in the related period.

 

	Three Months Ended October 31,				Six Months Ended October 31,
(Dollars in Thousands)	2024		2023		2024		2023
Basic net income (loss) per share computation:
Net income (loss) attributable to common stockholders	$	728	$	(2,071)	$	2,041	$	(4,637)
Weighted Average common shares – basic	13,593,766		13,497,061		13,593,766		13,529,629
Basic net income (loss) per share	$	0.05	$	(0.15)	$	0.15	$	(0.34)
Diluted net income (loss) per share computation:
Net income (loss) attributable to common stockholders	$	728	$	(2,071)	$	2,041	$	(4,637)
Weighted Average common shares	13,593,766		13,497,061		13,593,766		13,529,629
Incremental shares from assumed exercise of stock options	423,187		—		435,900		—
Adjusted weighted average share – diluted	14,016,953		13,497,061		14,029,666		13,529,629
Diluted net income (loss) per share	$	0.05	$	(0.15)	$	0.15	$	(0.34)

Schedule of antidilutive securities excluded from earnings per share calculations

The following table reflects the total potential common stock instruments outstanding at October 31, 2024 and 2023 including those that could have an effect on the future computation of dilution per common share, had their effect not been anti-dilutive.

	October 31,
	2024	2023
Total common stock equivalents	907,979	1,831,867